Report of a male patient with brain metastases from breast cancer

As in female patients, the clinical course in male patients with breast cancer is determined mainly by tumor stage. The literature contains very limited data on either the occurrence or the treatment of CNS metastases. This paper presents the case report of a 69-year-old man with multiple brain meta...

Full description

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 2003-10, Vol.12 (5), p.345-347
Main Authors: Nieder, C, Jost, P.J, Grosu, A.L, Peschel, C, Molls, M
Format: Article
Language:English
Subjects:
Aged
Biopsy, Needle
Brain metastases
Brain Neoplasms - radiotherapy
Brain Neoplasms - secondary
Breast cancer
Breast Neoplasms, Male - pathology
Breast Neoplasms, Male - therapy
Carcinoma, Intraductal, Noninfiltrating - pathology
Carcinoma, Intraductal, Noninfiltrating - therapy
Combined Modality Therapy
Disease Progression
Fatal Outcome
Humans
Male
Neoplasm Staging
Palliative Care - methods
Radiation therapy
Radiotherapy Dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As in female patients, the clinical course in male patients with breast cancer is determined mainly by tumor stage. The literature contains very limited data on either the occurrence or the treatment of CNS metastases. This paper presents the case report of a 69-year-old man with multiple brain metastases 7 years after a diagnosis of lymph-node positive breast cancer, which had earlier already spread to the bones and liver. Whole-brain irradiation with a total dose of 30 Gy resulted in palliation of symptoms. Nevertheless, survival was very short (7 weeks from diagnosis). Patients with metastatic breast cancer are at risk for the development of brain metastases. When performance status is poor the survival of patients with brain metastases is very limited. Treatment recommendations are the same as those for female patients with brain metastases from breast cancer.
ISSN:0960-9776
1532-3080
DOI:10.1016/S0960-9776(03)00109-7